Your HLA lab can now achieve 510(k) SBT HLA results
Interested? Talk to a Life Technologies HLA representative and learn
about the options now available.
Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger Sequencing Platform and HLA Typing Kits
Life’s Applied Biosystems™3500 Dx Genetic Analyzer and SeCore® kits constitute first sequence-based system cleared for HLA typing
CARLSBAD, CA – February 11, 2013—Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers CS2 and SeCore® HLA typing kits. The development represents additional execution against the company’s strategy to become a leader in the diagnostics market by offering both novel clinical assays and best-in-class molecular testing products.
Click on the image to view a larger version